Managing Quality in Cell Culture Media for More Reliable Biomanufacturing
September 16, 2025
The right cell culture media starting materials are a prerequisite for successful biopharma production.
8 min read
False
Advertisement
Latest
ADCs: Keeping Up With Characterization Demands
By Tran Pham
September 16, 2025
As antibody drug conjugates continue to evolve, so too must analytical approaches for characterization. Here’s a snapshot of just some of the interesting research taking place.
3 min read
Going Green Without Sacrificing Lab Equipment Performance
By Rob Coker
September 16, 2025
Single-use plastics remain essential in labs, but their environmental impact is hard to ignore...
4 min read
Making Self-Injection Work for Patients
September 15, 2025
Patients say they are ready for self-injectables, but are healthcare providers? And what further innovation in devices is needed?
9 min read
Bacteria and Viruses Join Forces in New Cancer Therapy Strategy
September 15, 2025
Columbia University researchers develop new platform that combines bacteria and viruses to attack cancer.
2 min read
Funding the Future of Drug Discovery
September 12, 2025
Investing in powerful, intuitive computational chemistry to boost productivity and increase global access to drug discovery technology.
3 min read
Millipedes and Medicinal Chemistry
September 11, 2025
Looking for the next generation of neuromodulators in unlikely places.
3 min read
The Brutality of the Investment Landscape
By Stephanie Vine
September 11, 2025
Michael Murray has spent decades advising on deal management and commercial strategy – and he has a lot of tips and advice for budding start-ups looking for investment.
11 min read
Cracking the β2AR Code for Diabetes and Obesity
September 10, 2025
By exploiting GRK2 bias, researchers are redefining how β2AR modulation can be applied in type 2 diabetes and obesity management.
2 min read
This Week’s Biopharma News: FDA to Release Complete Response Letters in Real Time
September 10, 2025
Our latest news roundup reports on Novartis’ proposed acquisition of Tourmaline Bio, GLP-1s being added to WHO’s lists of essential medicines, and new safety switches for cell and gene therapies.
3 min read
